Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥20.33B | ¥19.93B | +2.0% |
| Operating Income | ¥0.39B | ¥0.33B | +16.3% |
| Ordinary Income | ¥0.47B | ¥0.42B | +11.6% |
| Net Income | ¥0.60B | ¥0.27B | +123.2% |
| ROE | 6.6% | 3.1% | - |
Executive Summary
Cumulative results for Q3 of FY2026 were characterized by a modest increase in revenue, higher operating income, and a substantial increase in net income. The latter was dependent on a one-time gain on the sale of securities, which warrants attention. Revenue was ¥20.33B (+2.0% YoY), operating income was ¥0.39B (+16.3%), ordinary income was ¥0.47B (+11.6%), and net income was ¥0.60B (+123.2%). Operating income growth exceeding the revenue growth rate indicates a certain degree of cost absorption, but the sharp increase in net income was primarily attributable to a ¥0.45B gain on the sale of investment securities; this must be distinguished from an improvement in recurring earnings power.
Factors Affecting Performance
【Revenue】Revenue was ¥20.33B, representing a moderate increase of +2.0% YoY. While the core Chemicals Business grew to ¥17.60B (86.6% of total revenue, +5.3% YoY), the Building Materials Business declined to ¥2.74B (13.4% of total revenue, -14.9% YoY), resulting in divergent performance trends between the businesses.
【Profit and Loss】Operating income was ¥0.39B (+16.3% YoY), exceeding the revenue growth rate and reflecting a certain degree of operating leverage. Ordinary income was ¥0.47B (+11.6% YoY), with non-operating income, primarily ¥0.08B in dividend income, contributing to the increase. Net income was ¥0.60B (+123.2% YoY); however, pretax income of ¥0.87B included a ¥0.45B gain on the sale of investment securities (a net effect of approximately ¥0.40B after a ¥0.05B extraordinary loss), meaning that the growth rate would be significantly lower excluding this one-time factor. Accordingly, the company can be assessed as having achieved higher revenue and earnings on an operating basis, but the sustainability of net income growth is limited.
Segment Analysis
The Chemicals Business recorded revenue of ¥17.60B (+5.3% YoY), segment profit of ¥0.46B (+24.0% YoY), and a profit margin of 2.6%, representing growth in both revenue and profit and serving as the core business, accounting for 85.1% of total profit. The Building Materials Business recorded revenue of ¥2.74B (-14.9% YoY), segment profit of ¥0.08B (-38.8% YoY), and a profit margin of 3.0%, representing declines in both revenue and profit. Although smaller in scale, the performance gap with the core business has widened. Both businesses have profit margins of around 3%, sharing a common low-margin structure.
Key Financial Metrics
【Profitability】The operating margin was 1.9%, the gross margin was 9.9%, and the net profit margin was 2.9%, all reflecting a low-margin wholesale and trading-company business model. ROE was 6.6%, decomposed into a 2.9% net profit margin × 1.275x total asset turnover × 1.77x financial leverage; the low net profit margin was the primary factor depressing ROE. 【Cash Flow Quality】Accounts receivable were ¥5.70B (35.7% of total assets), and DSO was 77 days, indicating that the lengthening collection period for operating receivables is tying up working capital. 【Investment Efficiency】ROIC is estimated at approximately 5%, and although total asset turnover is at a certain level, the low operating margin is constraining the return on invested capital. 【Financial Soundness】The equity ratio was 56.6%, the current ratio was 186.4%, the quick ratio was 172.2%, and the debt-to-equity ratio was 0.77x, indicating conservative and sound levels of both short-term liquidity and capital structure.
Cash Flow Analysis
Because figures from the statement of cash flows have not been disclosed, an examination of the balance sheet trends indicates that cash and deposits increased to ¥1.81B from ¥1.47B in the same period of the previous year, while investment securities declined from ¥2.98B, suggesting that the recovery of funds through the sale of securities was one factor behind the increase in cash. Accounts receivable of ¥5.70B and electronically recorded monetary claims of ¥2.62B together account for a significant portion of total operating receivables, and the 77-day DSO suggests that it may take time for improved operating income to be converted into cash. Accounts payable were ¥4.32B, up from ¥3.99B in the same period of the previous year, and adjustments on the payment side also affected cash management. Overall, disclosure of future operating cash flow would be useful for corroborating the quality of operating income.
Earnings Quality
There was a substantial difference between operating income of ¥0.39B and pretax income of ¥0.87B, primarily due to the one-time ¥0.45B gain on the sale of investment securities. Non-operating income was primarily composed of ¥0.08B in dividend income, providing a certain degree of stability as recurring income, whereas the gain on sale recorded as extraordinary income has low repeatability. Of net income of ¥0.60B, the portion based on recurring business activities remained close to ordinary income of ¥0.47B, and the divergence between net income and ordinary income was primarily attributable to extraordinary gains and losses. Comprehensive income was ¥0.47B, below net income of ¥0.60B, primarily due to valuation difference on securities of -¥0.11B, indicating that fluctuations in the market prices of held securities may continue to be a factor affecting performance.
Earnings Forecast and Guidance
Progress toward the full-year forecast was 74.8% for revenue, 81.3% for operating income, 82.3% for ordinary income, and 95.0% for net income. Operating income and ordinary income are progressing favorably, exceeding the standard Q3 progress rate of 75%. Meanwhile, the 95.0% progress rate for net income reflects an early contribution from the gain on the sale of investment securities and should be viewed separately from the pace of recurring earnings growth. The full-year forecast is revenue of ¥27.20B (+0.3% YoY), operating income of ¥0.48B (+2.4% YoY), and ordinary income of ¥0.57B (-2.9% YoY), with operating income assessed as having a relatively high probability of achievement.
Shareholder Returns
The full-year dividend forecast is ¥100 per share, including the Q2 dividend of ¥50. The payout ratio based on net income of ¥0.60B (on a progress basis) is 9.6%, substantially below the 60% level generally regarded as an indicator of sustainability. However, because current net income includes a gain on the sale of investment securities, the effective dividend burden would be higher than the reported payout ratio if recurring earnings were used as the basis. Given the conservative capital structure, with an equity ratio of 56.6%, the company appears to have sufficient financial capacity to pay dividends.
Risk Factors
-
Low gross margin and low operating margin: With a gross margin of 9.9% and an operating margin of 1.9%, both below the industry median operating margin of 3.3%, the business model is susceptible to pressure on operating income from price competition and rising procurement costs.
-
Lengthening accounts receivable collection period: DSO was 77 days, with accounts receivable of ¥5.70B and electronically recorded monetary claims of ¥2.62B tying up working capital. A lengthening collection period may delay the conversion of operating income into cash.
-
Dependence of net income on one-time factors and decline in the Building Materials Business: The increase in net income was heavily dependent on the ¥0.45B gain on the sale of investment securities, limiting its repeatability. In addition, the Building Materials Business deteriorated, with revenue down -14.9% YoY and segment profit down -38.8%, widening the performance gap with the core Chemicals Business.
Industry Benchmark (For Reference; Compiled by the Company)
Industry Benchmark (trading)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 1.9% | 3.3% (1.8%–5.0%) | −1.4pt |
| Net Profit Margin | 2.9% | 3.1% (1.4%–6.3%) | −0.2pt |
Both the operating margin and net profit margin are below the industry median, placing the company’s profitability at a relatively low level within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 2.0% | 5.2% (-4.1%–8.6%) | −3.2pt |
The revenue growth rate is also below the industry median, indicating that top-line growth is somewhat low relative to the industry.
※Source: Compiled by the Company
Key Points from the Financial Results
-
The core Chemicals Business drove overall performance through higher revenue and profit (revenue +5.3%, segment profit +24.0%), while the Building Materials Business experienced declines in both revenue and profit (revenue -14.9%, profit -38.8%), reflecting divergent trends and a widening gap within the business portfolio.
-
The 95.0% full-year progress rate for net income was attributable to the gain on the sale of investment securities and must be distinguished from the recurring performance pace indicated by the progress rates for operating income and ordinary income (81.3% and 82.3%, respectively).
-
While financial soundness is favorable (equity ratio of 56.6%, current ratio of 186.4%), the low-margin structure, reflected in the 1.9% operating margin and 9.9% gross margin, and the 77-day accounts receivable collection period represented by DSO are observed as structural challenges to medium- to long-term profitability and capital efficiency.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings briefing data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly available earnings data. Investment decisions should be made at your own responsibility, after consulting a professional as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 performance was operationally solid but reported net income was materially boosted by a non-recurring securities sale gain. Revenue increased 2.0% YoY to ¥20.33bn for the nine-month cumulative period. Operating income rose faster, by 16.3% YoY to ¥386m, reflecting improved gross profit generation despite higher SG&A. Gross profit increased 6.3% YoY to ¥2.01bn. The gross margin expanded by approximately 40bp YoY to 9.9%. Operating margin improved by approximately 20bp YoY to 1.9%, but remains structurally low. SG&A increased 4.2% YoY to ¥1.62bn, exceeding revenue growth and tempering the conversion of gross-profit growth into operating profit. Ordinary income increased 11.6% YoY to ¥469m. Dividend income of ¥75m represented a meaningful 16.0% of ordinary income and supported recurring pre-tax profitability. Net income more than doubled to ¥598m, up 123.2% YoY, but this was principally attributable to a ¥446m gain on sale of investment securities. The net securities-sale gain after the ¥46m related loss was approximately ¥400m, equivalent to roughly 67% of reported net income. Consequently, the 2.9% net margin and 8.8% annualized ROE overstate the earnings power implied by the 1.9% operating margin. Comprehensive income of ¥472m was below net income because valuation and foreign-currency translation movements were negative. The Science business remained the core profit contributor, while the Building Materials business experienced a revenue and profit decline. The balance sheet is liquid, with a 186.4% current ratio and ¥5.20bn of working capital. Financial leverage is moderate at 1.77x and D/E is 0.77x, while interest coverage is exceptionally strong at 134.7x. The full-year operating-income forecast is within reach, with Q3 cumulative progress of 81.3% against the ¥475m target. In contrast, Q3 net-income progress of 95.0% against the ¥630m forecast is unusually advanced and largely reflects the one-time investment-security disposal gain rather than a comparable uplift in underlying operations.
Profitability Analysis
Annualized ROE is 8.8%, decomposed into a 2.9% net profit margin, 1.700x asset turnover, and 1.77x financial leverage. The principal limitation in the DuPont profile is margin rather than asset utilization or leverage: annualized asset turnover is relatively healthy for a trading-oriented business, while the operating margin is only 1.9%. Financial leverage contributes to shareholder returns but is not aggressive, as D/E is 0.77x. The largest YoY improvement was in net profit margin, but this was not an operating improvement because pre-tax income included a ¥446m gain on sale of investment securities. At the operating level, gross margin improved about 40bp to 9.9%, supporting a 16.3% increase in operating income on only 2.0% revenue growth. This indicates favorable gross-profit mix and/or procurement and pricing discipline during the period. However, SG&A grew 4.2% YoY, faster than sales, and therefore represents a negative operating-leverage trend. The low 9.9% gross margin is a material quality alert: it leaves profitability sensitive to modest changes in selling prices, raw-material costs, logistics costs, and product mix. The 1.9% EBIT margin is also below the 5% efficiency threshold and limits the capacity to absorb cyclical volume weakness. Interest expense was only ¥3m, and interest coverage of 134.7x confirms that financing costs are not constraining profitability. The five-factor analysis shows a tax burden of 0.687, while the interest-burden ratio above 1.0 results from substantial non-operating and extraordinary gains relative to EBIT rather than from core operating earnings. Annualized ROIC of 4.9% is below the 5% warning threshold, indicating that the current operating return on the capital base remains insufficiently strong. The priority for sustainable return improvement is therefore widening the operating margin and ROIC, rather than increasing financial leverage.
Growth Assessment
Revenue growth was modest at 2.0% YoY, but operating income growth of 16.3% indicates an improved gross-profit outcome. The Science business grew revenue 5.3% YoY to ¥17.60bn and segment profit 24.1% to ¥461m. Its segment margin improved from 2.2% to 2.6%, establishing Science as the core business by operating-income contribution. The Building Materials business saw revenue decline 14.9% YoY to ¥2.74bn, while segment profit fell 38.8% to ¥81m. Its segment margin declined from 4.1% to 3.0%, indicating pressure from lower scale and/or less favorable mix. Science accounted for 86.5% of consolidated segment revenue and 85.1% of total segment profit, increasing earnings concentration in that business. Head-office costs improved from ¥172m to ¥156m, partially supporting consolidated operating-income growth. The full-year revenue forecast is ¥27.20bn, and Q3 cumulative progress is 74.8%, broadly in line with the standard 75% progress rate. Operating-income progress is 81.3%, 6.3 percentage points ahead of the standard Q3 run rate, indicating that the ¥475m full-year target appears achievable if margins are maintained. Ordinary-income progress is 82.3%, also ahead of the standard run rate, supported partly by dividend income. Full-year guidance calls for only 2.4% operating-income growth and a 2.9% decline in ordinary income, implying a more conservative final-quarter outlook than the Q3 cumulative trend. Net income has reached 95.0% of the full-year target, but the gain on sale of investment securities means this progress rate should not be interpreted as evidence of comparable recurring earnings momentum. The sustainability of profit growth depends primarily on continued Science-business margin improvement and stabilization in Building Materials.
Financial Health
Liquidity is sound. Current assets of ¥11.22bn exceed current liabilities of ¥6.02bn, producing a current ratio of 186.4% and working capital of ¥5.20bn. The quick ratio of 172.2% indicates that liquidity coverage is strong even before relying on inventory monetization. Cash and deposits increased 23.5% YoY to ¥1.81bn. Trade receivables were broadly stable at ¥5.70bn, while electronically recorded monetary claims increased to ¥2.62bn. Inventories declined 17.4% YoY to ¥852m, which supports balance-sheet efficiency and reduces inventory carrying risk. Current liabilities declined 7.1% YoY to ¥6.02bn, led by the absence of prior-period short-term borrowings in the current reporting balance sheet classification and lower other current obligations. Trade payables increased 8.4% YoY to ¥4.32bn, while electronically recorded obligations increased 8.9% to ¥1.20bn. Total liabilities decreased 7.2% YoY to ¥6.93bn, whereas total equity increased 3.6% YoY to ¥9.03bn. The equity ratio improved to 56.6% from 53.9%, strengthening the capital buffer. D/E of 0.77x is within the conservative benchmark range and well below the 2.0x level that would indicate aggressive leverage. Interest coverage of 134.7x further supports a low near-term solvency risk. Investment securities remain substantial at ¥2.98bn, representing 18.7% of total assets; this portfolio provides financial flexibility but exposes comprehensive income and capital to market-value fluctuations. Retained earnings increased by ¥508m to ¥5.29bn, supporting equity accumulation after dividends and the period's reported profit.
Notable B/S Changes
Cash and deposits: +¥0.35bn (+23.5%) to ¥1.81bn - strengthens immediate liquidity. Inventories: -¥0.18bn (-17.4%) to ¥0.85bn - indicates lower inventory commitment and supports working-capital efficiency. Current liabilities: -¥0.46bn (-7.1%) to ¥6.02bn - improves short-term liquidity coverage. Total liabilities: -¥0.54bn (-7.2%) to ¥6.93bn - contributes to improved balance-sheet resilience. Retained earnings: +¥0.51bn (+10.6%) to ¥5.29bn - supports equity accumulation and dividend capacity. Investment securities: -¥0.45bn (-13.1%) to ¥2.98bn - consistent with the period's securities disposal gain; portfolio valuation and future gain availability remain relevant.
Cash Flow Quality
The operating cash-flow, investing cash-flow, financing cash-flow, free-cash-flow and capital-expenditure figures are not reported in the provided financial data. Earnings quality can nevertheless be assessed from the income statement and working-capital balance sheet. Reported net income of ¥598m was materially influenced by the ¥446m gross gain on sale of investment securities and the ¥46m related loss, resulting in an approximately ¥400m net extraordinary gain. This non-recurring item accounts for about two-thirds of net income and weakens the comparability of reported earnings with ordinary operating performance. Ordinary income of ¥469m was more reflective of ongoing profitability than profit before tax of ¥870m. Dividend income of ¥75m also made a meaningful contribution to ordinary income, although it is less directly tied to the company’s operating margin than segment earnings. Inventory declined by approximately ¥180m YoY, which is favorable for working-capital discipline. However, the quality alert for 77-day DSO is material: receivable collection is slower than the 60-day benchmark and ties up capital in the sales cycle. The company holds ¥5.70bn in trade receivables and ¥2.62bn in electronic monetary claims, making collection discipline a key determinant of cash conversion. The combination of low operating margin and elevated receivable days means that modest delays in collection could have a disproportionate effect on operating cash generation. The reduction in inventories partly offsets this concern, but sustained improvement in receivable days would provide stronger evidence of cash conversion quality.
Dividend Sustainability
The disclosed interim dividend is ¥50 per share, and the full-year forecast dividend is ¥100 per share. Based on Q3 cumulative net income, the calculated dividend-only payout ratio using the disclosed ¥50 interim payment is 9.6%. Based on the full-year EPS forecast of ¥700.78 and planned DPS of ¥100, the prospective full-year dividend payout ratio is approximately 14.3%. This is a conservative payout level and provides substantial accounting earnings coverage. Retained earnings of ¥5.29bn and total equity of ¥9.03bn provide a solid capital base for the indicated dividend. The balance sheet also has healthy current liquidity, with a current ratio of 186.4%. However, the period’s net income includes a material one-time gain on sale of investment securities, so dividend affordability should be evaluated primarily against recurring ordinary and operating profitability rather than Q3 reported net income alone. The planned ¥100 DPS remains modest relative to the projected ¥630m full-year net income and therefore does not appear to require elevated leverage. Dividend sustainability will be best supported by maintaining Science segment profitability, restoring Building Materials earnings, and converting receivables into cash efficiently.
Risk Assessment
Business risks include Low-margin risk: the 9.9% gross margin and 1.9% EBIT margin leave earnings vulnerable to small adverse movements in selling prices, input costs, freight costs, or product mix., Segment concentration risk: Science generates 85.1% of total segment profit, increasing group dependence on demand and margins in this core business., Building Materials downturn risk: segment revenue declined 14.9% YoY and segment profit fell 38.8%, indicating weaker demand and/or margin conditions that could continue to weigh on consolidated growth., Working-capital risk: 77-day DSO exceeds the 60-day benchmark, creating exposure to slower customer collections and weaker cash conversion., Investment-market risk: investment securities equal 18.7% of assets, and negative other comprehensive income during the period demonstrates sensitivity of equity to security valuations and currency translation..
Financial risks include Reported net income is not fully recurring: the approximately ¥400m net gain from investment-security sales materially inflated Q3 earnings and may not recur., Capital-efficiency risk: annualized ROIC of 4.9% is below the 5% warning threshold, indicating limited returns on the capital deployed in the business., Receivable concentration risk: trade receivables and electronic monetary claims together total approximately ¥8.32bn, a large portion of current assets., Moderate leverage requires continued discipline: D/E is manageable at 0.77x, but the low operating margin limits the cushion against a significant earnings downturn..
Key concerns include Highest priority: improve sustainable operating profitability, as the 1.9% EBIT margin is below the 5% efficiency benchmark and cannot be remedied by non-recurring asset gains., High priority: monitor Science segment margin retention and whether Building Materials can stabilize after its double-digit revenue and profit decline., High priority: monitor DSO and the balance of trade receivables plus electronic claims, as collection performance is central to cash conversion., Medium priority: distinguish recurring ordinary income from gains on investment-security disposals when assessing earnings trajectory and full-year performance., Medium priority: monitor investment-security valuation movements because the portfolio is material relative to assets and equity..
Investment Implications
Key takeaways include Core operating performance improved, with operating income up 16.3% YoY and gross margin up approximately 40bp to 9.9%., Science is the principal earnings engine, delivering ¥461m of segment profit, while Building Materials weakened materially., Reported net income growth of 123.2% YoY was predominantly non-recurring because of the ¥446m gain on sale of investment securities., Liquidity and solvency are sound, supported by a 186.4% current ratio, 56.6% equity ratio, 0.77x D/E, and 134.7x interest coverage., Annualized ROE of 8.8% is acceptable but is flattered by extraordinary gains; annualized ROIC of 4.9% and EBIT margin of 1.9% highlight the need for better operating capital efficiency., The full-year operating-income target appears achievable based on 81.3% Q3 progress, whereas net-income progress should be interpreted cautiously because of one-time gains..
Metrics to watch include Science segment revenue growth and segment margin, Building Materials revenue recovery and segment-profit trend, Consolidated gross margin and EBIT margin, Annualized ROIC relative to the 5% warning level, DSO, trade receivables, and electronic monetary claims, Investment-security sales gains and valuation movements, Progress toward full-year operating income of ¥475m and ordinary income of ¥570m.
Regarding relative positioning, The company presents a conservatively financed and liquid profile, but its operating economics are weak relative to standard profitability benchmarks. Asset turnover and balance-sheet resilience are constructive, whereas the sub-5% annualized ROIC, 1.9% EBIT margin, low gross margin, and elevated DSO place greater importance on margin discipline and working-capital management than on leverage reduction.